Baraclude tablet 0.5 mg 30’s

 9,000.00


Active Pharmaceutical Ingredient:
Drug Strength: 0.5 mg
Drug Form : Tablet
Pack Size : 30s
Does this requires a prescription ?Yes

Baraclude tablet contains Entecavir | belongs to Anti-cytomegalovirus agent

SKU: pg_2409_3211 Categories: , ,

Alternate brands

  • Zekavir tablet 0.5 mg 3×10’s
     6,690.00
  • You can save 2310
  • Xclude tablet 0.5 mg 3×10’s
     10,200.00
  • You will pay -1200 more
  • Virunix-B tablet 0.5 mg 30’s
     5,500.00
  • You can save 3500
  • Viro-quit tablet 0.5 mg 3×10’s
     10,200.00
  • You will pay -1200 more
  • Truvada tablet 0.5 mg 3×10’s
     10,200.00
  • You will pay -1200 more

    Reviews

    There are no reviews yet.

    Be the first to review “Baraclude tablet 0.5 mg 30’s”

    How it works

    Baraclude tablet 0.5 mg 30’s stops the virus from making copies of itself. This helps in reducing the quantity of virus in the patient's body.

    Side effects

    Major & minor side effects for Baraclude tablet 0.5 mg 30’s

    • Allergy severe
    • Diarrhoea
    • Elevated Liver Enzymes
    • Insomnia
    • Fatigue
    • Headache
    • Dizziness

    Uses of Baraclude tablet 0.5 mg 30’s

    What is it prescribed for?

    • Chronic Hepatitis B

      Baraclude tablet 0.5 mg 30’s is used in the treatment of chronic hepatitis B infection, if no nucleoside reverse transcriptase inhibitors (NRTIs) like lamivudine were previously used or if resistance is developed to the existing NRTI therapy.

    Concerns

    Frequently asked questions

    • Onset of action

      The time at which this medicine shows its effect is not clinically established.

    • Duration of Effect

      There is no well-established clinical data available regarding the duration of action of this medicine.

    • Safe with Alchohol?

      Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

    • Is it habit forming?

      No habit forming tendencies were reported.

    • Usage in pregnancy?

      This medicine is not recommended for use in pregnant women unless strictly indicated. The benefits and risks should be discussed with the doctor before using this medicine.

    • Usage while breast-feeding?

      This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

    When not to use?

    • Allergy

      This medicine is not recommended for use in patients with a known allergy to Baraclude tablet 0.5 mg 30’s.

    Warnings

    Warnings for special population
    • Pregnancy

      This medicine is not recommended for use in pregnant women unless strictly indicated. The benefits and risks should be discussed with the doctor before using this medicine.

    • Breast-feeding

      This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

    General Warnings
    • Exacerbation of Hepatitis B

      Discontinuation of Baraclude tablet 0.5 mg 30’sor any other anti-Hepatitis B therapy may cause severe acute exacerbation of the HBV infection. Monitoring of liver function is recommended for at least a few months after stopping the treatment with this medicine. Further initiation of anti-Hepatitis B therapy may be warranted in a few cases.

    • HIV co-infection

      Baraclude tablet 0.5 mg 30’s is not recommended for use in patients who are infected with human immunodeficiency virus (HIV) and not on highly active antiretroviral therapy (HAART) therapy for HIV due to the risk of development of resistance to HIV NRTIs.

    • Lactic Acidosis

      This medicine is not recommended for use in patients with severe liver dysfunction due to the risk of lactic acidosis (increased acid in the blood). Frequent clinical monitoring for lactic acidosis is recommended while taking this medicine. Any symptoms like difficulty in breathing, irregular heartbeats, dark-coloured urine, and yellow colored skin and eyes should be reported to the doctor on priority.

    Dosage

    • Missed Dose

      If a dose of Baraclude tablet 0.5 mg 30’s is missed, take the dose as soon as you remember. If it is almost the time for the next dose, skip the missed dose and take the next dose. Do not double the dose to make up for the missed one.

    • Overdose

      Seek emergency medical treatment or contact the doctor in case of an overdose.

    Interactions

    Interaction with Medicines
    • Metformin moderate
    • Aminoglycoside antibiotics moderate
    • NSAIDs moderate
    Disease interactions
    • moderate

      Baraclude tablet 0.5 mg 30’sshould be used with extreme caution in patients with renal dysfunction. Renal function should be assessed before initiating the treatment with this medicine. Appropriate dosage adjustment should be made based on the renal function.

    Food interactions
    • The desired effect of Baraclude tablet 0.5 mg 30’swill not be achieved if it is taken with food. Hence, it is advisable to take this medicine on an empty stomach unless otherwise specified by the doctor. It is recommended that you take this medicine 2 hours before or after meals.

    General Instructions

    Do not use Baraclude tablet 0.5 mg 30’sfor any conditions other than those specified by the doctor. Do not share the medicine with anyone else. Report to the doctor all your medical conditions and current medicines before taking this medication. Report any undesired effects or lack of improvement to the doctor on priority.

    Other details

    • To be taken on an empty stomach
    • To be taken as instructed by doctor
    • Does not cause sleepiness

    References

    Additional Information>

    what are the adverse effects of Baraclude tablet 0.5 mg 30’s?

    Headache, fatigue, dizziness, nausea, insomnia, raised ALT, exacerbations of hepatitis, GI upset, somnolence.

    What happens if I miss a dose of Baraclude tablet 0.5 mg 30’s?

    Adults: Nucleoside naive patients, 0.5 mg once daily. Lamivudine-refractory patients, 1 mg once daily at least 2 hr before or after a meal. Children: Not recommended.

    One of the following licensed pharmacy from the nearest location will deliver Baraclude tablet 0.5 mg 30’s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

    Questions and Answers

    There are no questions yet. Be the first to ask a question about this product.

    Only registered users are eligible to enter questions

    Authentic

    Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.

    Affordable

    We work hard to bring you unimaginable discounts without compromising on quality.

    Secure

    We uses SSL (standard security technology) to ensure data privacy of all our customers.

    We operate as a licensed pharmacy in Pakistan with License No. 2420

    Customer Service available Mon - Sat 10am - 6pm

    Medicalstore.com.pk © All rights reserved

    Made with ❤ by Dairah